心血管代谢风险.pptVIP

Cardiometabolic Risk: Evaluation Treatment in Your Patient Population Why Focus on Cardiometabolic Risk? A comprehensive approach to patient care; Multiple disease pathways and risk factors are considered to facilitate earlier intervention Early assessment and targeted intervention are needed to treat and prevent all risk factors associated with CVD and diabetes Cardiometabolic Risk Gives a comprehensive picture of a patient’s health and potential risk for future disease and complications Is inclusive of all risks related to metabolic changes associated with CVD Accommodates emerging risk factors as useful predictive tools Focuses clinical attention to the value of systematic evaluation, education, disease prevention and treatment Supports an integrated approach to care The State of Risk 2 out of 3 Americans are overweight or obese More than 70 million (nearly 1 in 4) Americans have varying degrees of insulin resistance There are an estimated 54 million (more than 1 in 6) Americans with prediabetes Nearly 1 in 4 U.S. adults has high cholesterol 1 in 3 American adults has high blood pressure Direct and Indirect Cost of CVD and Diabetes Cardiometabolic Risk - Graphic Non-modifiable Age Race/ethnicity Gender Family history Overweight Abnormal lipid metabolism Inflammation, hypercoagulation Hypertension Smoking Physical inactivity Unhealthy diet Insulin resistance Case - Mr. Martin 47-year-old African American man, hasn’t seen doctor in years Works as a truck driver, eats mostly fast food Smokes 1 pack per day At health fair found to have BP = 146/86, total cholesterol = 210 Weight = 230 lbs; BMI = 29 kg/m2 Family history of HTN and diabetes What’s Mr. Martin’s Cardiometabolic Risk? Age 47 Race/ethnicity African American Gender Male Family history HTN and diabetes Overweight/obesity BMI = 29 Abnormal lipid metab TC = 210 Hypertension BP = 146/86 Smoking 1 pack per day Physical Inactivity Yes Unhealthy diet Fast food diet Non-ModifiableRisk